mRNA |
foretinib |
CTRPv2 |
pan-cancer |
AAC |
-0.029 |
0.4 |
mRNA |
XL-184 |
GDSC1000 |
pan-cancer |
AAC |
0.027 |
0.4 |
mRNA |
selumetinib:decitabine (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.027 |
0.4 |
mRNA |
decitabine:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.023 |
0.4 |
mRNA |
HG-5-88-01 |
GDSC1000 |
pan-cancer |
AAC |
-0.037 |
0.4 |
mRNA |
lenvatinib |
CTRPv2 |
pan-cancer |
AAC |
0.029 |
0.4 |
mRNA |
MLN2480 |
CTRPv2 |
pan-cancer |
AAC |
0.043 |
0.4 |
mRNA |
salermide |
CTRPv2 |
pan-cancer |
AAC |
0.036 |
0.4 |
mRNA |
canertinib |
CTRPv2 |
pan-cancer |
AAC |
0.029 |
0.4 |
mRNA |
VU0155056 |
CTRPv2 |
pan-cancer |
AAC |
0.029 |
0.4 |